Overview
Illumina provides next-generation sequencing (NGS) and microarray technologies for life science research, translational genomics, and molecular diagnostics. Their sequencing by synthesis (SBS) platforms offer high-throughput, scalable solutions supporting applications in cancer research, reproductive health, microbiology, and more. These tools enable pharmaceutical R&D by accelerating genomic discoveries and improving workflows through integrated technology solutions.
Frequently asked questions
- What sequencing technologies does Illumina offer?
- Illumina offers next-generation sequencing (NGS) platforms using sequencing by synthesis (SBS) technology, providing ultra-high throughput, scalability, and support for single-read and paired-end libraries across benchtop and production-scale systems.
- What applications are supported by Illumina solutions?
- Illumina genomic solutions support diverse areas including reproductive and genetic health, cancer research, microbiology, translational genomics, and molecular diagnostics.
- What types of products does Illumina provide for pharma R&D?
- Illumina provides a broad range of sequencing platforms, microarray products, and integrated technology solutions designed for genomic analysis, research innovation, and workflow optimization in life sciences.